An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)

Enrolling by invitation

Conditions studied: Diabetes, Diabetes Mellitus, Type 2, Medullary Thyroid Carcinoma, Weight Management

In brief

This study is conducted in the United States of America (USA). The aim of the study is to monitor the number of annual new adult cases of medullary thyroid carcinoma (MTC) and to establish a registry for these new cases in order to identify any possible increase related to the introduction of liraglutide, exenatide once-weekly, and other GLP-1 receptor agonists into the US market.

Key facts

Study ID

NCT01511393

Run by

Novo Nordisk A/S

People needed

6750

Starts

2012-01-01

Expected to finish

2039-12-01

Last updated by the study team

2023-06-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• A record of medullary thyroid carcinoma (MTC) identified from state/regional population-based cancer registries
• At least 18 years or older.
• There are no other inclusion or exclusion criteria.

Where it is running

• United BioSource, LLC — Morgantown, West Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.